Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Emmaus Life Sciences's pe ratio was 43.4× on Apr 30, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 43.4× | −520.9 |
| 2013 | Oct 31, 2013 | 564.3× | – |
See a number that looks wrong?